Search Results

Showing results 9941 - 9950 for 2023

Weill Department of Medicine | Weill Cornell Medicine

...Website Annual Report Learn more about our department's achievements in 2023....

https://medicine.weill.cornell.edu/?page=166

Weill Department of Medicine | Weill Cornell Medicine

...Website Annual Report Learn more about our department's achievements in 2023....

https://medicine.weill.cornell.edu/?page=165

Digging Into a Decades-Old Hepatitis B Mystery Suggests a New Potential Treatment | Graduate School of Medical Sciences

...options IMP Career Outcomes IMP Entering Class IMP RetreatsToggle IMP Retreats menu options IMP Retreat 2023...

https://gradschool.weill.cornell.edu/news/digging-decades-old-hepatitis-b-mystery-suggests-new-potential-treatment

Scientists Detail Major Mechanism Lung Cancers Use to Evade Immune Attack | Obstetrics & Gynecology

...Home About Us Scientists Detail Major Mechanism Lung Cancers Use to Evade Immune Attack January 10, 2023...

https://obgyn.weillcornell.org/news/scientists-detail-major-mechanism-lung-cancers-use-evade-immune-attack

6th WCM Annual Diversity Week, April 15 -19 | Office of Diversity and Inclusion

...Week 2018 WCM Diversity Week 2019 WCM Diversity Week 2021 WCM Diversity Week 2022 WCM Diversity Week 2023...

https://diversity.weill.cornell.edu/events/6th-wcm-annual-diversity-week-april-15-19

Methionine metabolism controls the B cell EBV epigenome and viral latency. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:26pm Title Methionine metabolism controls the B cell EBV...

https://rothlab.weill.cornell.edu/publications/methionine-metabolism-controls-b-cell-ebv-epigenome-and-viral-latency

Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:23pm Title Combined EZH2 and Bcl-2 inhibitors as precision...

https://rothlab.weill.cornell.edu/publications/combined-ezh2-and-bcl-2-inhibitors-precision-therapy-genetically-defined-dlbcl-subtypes

Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:22pm Title Epigenetic reprogramming sensitizes immunologically...

https://rothlab.weill.cornell.edu/publications/epigenetic-reprogramming-sensitizes-immunologically-silent-ebv-lymphomas-virus-directed

Otolaryngologist and pediatric oncologist perspectives on the role of fine needle aspiration in diagnosing pediatric head and neck masses. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:18pm Title Otolaryngologist and pediatric oncologist perspectives...

https://rothlab.weill.cornell.edu/publications/otolaryngologist-and-pediatric-oncologist-perspectives-role-fine-needle-aspiration

Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:17pm Title Ibrutinib significantly inhibited Bruton's tyrosine...

https://rothlab.weill.cornell.edu/publications/ibrutinib-significantly-inhibited-brutons-tyrosine-kinase-btk-phosphorylationin-vitro

Showing results 9941 - 9950 for 2023